Go beyond "keep LDL low" — understand lipid biology, debunk statin myths with evidence, learn the dietary interventions that actually work, and develop a treatment mindset grounded in the real science of cardiovascular risk.
Cholesterol management has more misinformation surrounding it than almost any other area of cardiology. Patients stop their statins based on things they read online. They believe dietary changes they read about will bring their LDL from 180 to 70. They confuse HDL "goodness" with clinical outcomes.
This guide cuts through the noise with what the evidence actually shows. The statin myth-busting section alone — addressing the five most common reasons patients stop their medications — may be the most important content Dr. Nyange has put in writing.
LDL, HDL, triglycerides, non-HDL, and Lp(a) — what each particle does and why it matters.
Muscle damage, liver toxicity, natural alternatives, feeling fine, and the "forever drug" myth.
7 evidence-based dietary interventions with estimated mmHg and LDL reduction data.
Understanding ASCVD risk categories and what LDL target is right for your risk level.
How often to check lipids and what to watch for during statin therapy.
Ezetimibe, PCSK9 inhibitors, and bempedoic acid — when and why they're used.
"The patients I worry about most are not the ones with LDL of 200 — they're the ones with LDL of 200 who stopped their statin because of something they read online. Statin misinformation is a genuine public health problem, and correcting it is part of my job."
The clinical depth that turns good intentions into real LDL reduction.
Get Cholesterol Guide — $37